A retrospective study assessing the anatomical changes seen in MacTel eyes on OCT after intravitreal anti-VEGF therapy for SRNVM and associated functional outcomes with a long duration of follow-up
Latest Information Update: 03 Sep 2021
At a glance
- Drugs Bevacizumab (Primary) ; Ranibizumab (Primary)
- Indications Retinal telangiectasis
- Focus Therapeutic Use
Most Recent Events
- 03 Sep 2021 New trial record